Omega Diagnostics Group Plc (ODX):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Omega Diagnostics Group Plc (ODX) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7873
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:43
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Omega Diagnostics Group Plc (Omega) is a biotechnology company that provides in-vitro diagnostic products. The company provides products in the areas of allergy, food intolerance, autoimmune disease and infectious disease, among others. It also provides food intolerance and autoimmune tests for diseases such as renal disease, connective tissue disease and anaemia. Omega offers diagnosis of infectious diseases, including Syphilis, TB and Dengue Fever. The company supplies tests based on agglutination, enzyme immunoassay, fluorescence, rapid and micro-array technologies. It markets its diagnostic kits and systems to hospitals, blood banks, clinics and laboratories. The company operates in the UK, Germany and India. Omega is headquartered in Alva, the UK.

Omega Diagnostics Group Plc (ODX) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Omega Diagnostics Group Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Omega Diagnostics Group Plc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Omega Diagnostics Group Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Omega Diagnostics Group Plc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Omega Diagnostics Group Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Omega Diagnostics Group Plc, Medical Equipment, Deal Details 10
Partnerships 10
Omega Diagnostics Enters Into Licensing Agreement With Burnet Institute For CD4 POC Test 10
Omega Diagnostics Enters Into Licensing Agreement With Burnet Institute For Syphilis 11
Omega Diagnostics Enters into Distribution Agreement with Immunodiagnostic Systems 12
Omega Diagnostics Amends Licensing Agreement With Immunodiagnostic Systems 13
Equity Offering 14
Omega Diagnostics Group to Raise USD3 Million in Private Placement of Shares 14
Omega Diagnostics Group to Raise USD1.3 Million in Rights Offering of Shares 15
Omega Diagnostics Group Plc – Key Competitors 16
Omega Diagnostics Group Plc – Key Employees 17
Omega Diagnostics Group Plc – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Strategy And Business Planning 19
May 02, 2018: Omega Diagnostics: Closure of Omega Diagnostics GmbH 19
Financial Announcements 20
Dec 14, 2017: Omega Diagnostics Group:Interim Results for the Six Months Ended 30 September 2017 20
Jun 30, 2017: Omega Diagnostics Group: Final Results For The Year Ended 31 March 2017 23
Corporate Communications 34
Dec 14, 2017: Omega Diagnostics Group: CEO succession 34
Legal and Regulatory 35
Nov 01, 2017: Omega Diagnostics Group: Change of Registered Office 35
Jan 11, 2017: Omega Diagnostics Group: ISO accreditation for manufacturing facility in Pune, India 36
Other Significant Developments 37
Sep 27, 2018: Omega Diagnostics Group: Allergy CE-Mark and first Purchase Order 37
Apr 20, 2018: Omega Diagnostics: Allersys Distribution Agreement 38
Apr 10, 2018: Omega Diagnostics: Strategic Review of operations and Trading Update 39
Oct 16, 2017: Omega Diagnostics Group :Announces US Supply Agreement 41
Jan 27, 2017: Omega Diagnostics Group: Update on discussions with Immunodiagnostic Systems Holdings 42
Appendix 43
Methodology 43
About GlobalData 43
Contact Us 43
Disclaimer 43

List of Tables
Omega Diagnostics Group Plc, Medical Equipment, Key Facts, 2018 2
Omega Diagnostics Group Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Omega Diagnostics Group Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Omega Diagnostics Group Plc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Omega Diagnostics Group Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Omega Diagnostics Group Plc, Deals By Market, 2012 to YTD 2018 8
Omega Diagnostics Group Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Omega Diagnostics Enters Into Licensing Agreement With Burnet Institute For CD4 POC Test 10
Omega Diagnostics Enters Into Licensing Agreement With Burnet Institute For Syphilis 11
Omega Diagnostics Enters into Distribution Agreement with Immunodiagnostic Systems 12
Omega Diagnostics Amends Licensing Agreement With Immunodiagnostic Systems 13
Omega Diagnostics Group to Raise USD3 Million in Private Placement of Shares 14
Omega Diagnostics Group to Raise USD1.3 Million in Rights Offering of Shares 15
Omega Diagnostics Group Plc, Key Competitors 16
Omega Diagnostics Group Plc, Key Employees 17
Omega Diagnostics Group Plc, Other Locations 18
Omega Diagnostics Group Plc, Subsidiaries 18

List of Figures
Omega Diagnostics Group Plc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Omega Diagnostics Group Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Omega Diagnostics Group Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Omega Diagnostics Group Plc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Omega Diagnostics Group Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Omega Diagnostics Group Plc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Omega Diagnostics Group Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Omega Diagnostics Group Plc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Omega Diagnostics Group Plc (ODX):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Acorda Therapeutics Inc (ACOR)-製薬・医療分野:企業M&A・提携分析
    Summary Acorda Therapeutics Inc (Acorda) is a biopharmaceutical company that discovers, develops, and commercializes therapies for treating patients with neurological disorders. The company’s commercial products include Ampyra (dalfampridine), a treatment to improve walking in patients with multiple …
  • Wesco Aircraft Holdings Inc:企業の戦略・SWOT・財務分析
    Wesco Aircraft Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary Wesco Aircraft Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • China Resources Enterprise Ltd:企業の戦略的SWOT分析
    China Resources Enterprise Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • The Norinchukin Bank
    The Norinchukin Bank - Strategy, SWOT and Corporate Finance Report Summary The Norinchukin Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Slavneft-Megionneftegaz (MFGS):企業の財務・戦略的SWOT分析
    Summary Slavneft-Megionneftegaz (Megionneftegaz), a subsidiary of Slavneft, is an oil and gas company that operates oil fields. The company’s activities include appraisal of oil and gas fields, oil and gas production, and well drilling and operation. Megionneftegaz develops and introduces advanced t …
  • MindTree Ltd.:企業の戦略・SWOT・財務情報
    MindTree Ltd. - Strategy, SWOT and Corporate Finance Report Summary MindTree Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Cosan S.A. Industria e Comercio (CSAN3):電力:M&Aディール及び事業提携情報
    Summary Cosan S.A. Industria e Comercio (Cosan), a subsidiary of Cosan Limited, is an integrated bioenergy company. It invests in diversified industries including agribusiness, fuel and natural gas distribution, and lubricants. The company distributes lubricants, fuel oil, and piped natural gas; and …
  • Y.S.P. Southeast Asia Holding Berhad (YSPSAH):企業の財務・戦略的SWOT分析
    Y.S.P. Southeast Asia Holding Berhad (YSPSAH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • Ipsen SA (IPN):製薬・医療:M&Aディール及び事業提携情報
    Summary Ipsen SA (Ipsen) is a global specialty biopharmaceutical company that manufactures and distributes drugs for the treatment of cancer and rare and neurological diseases. The company develops and commercializes novel medicines in cancer, neuroscience and rare diseases. It also offers products …
  • Vertical Computer Systems Inc (VCSY):企業の財務・戦略的SWOT分析
    Summary Vertical Computer Systems Inc (VCSY) is a technology company that develops and markets of application software, cloud-based and software services, internet core technologies, and intellectual property assets. The company provides products such as siteflash, responseflash, empath, snappnet, a …
  • Gulfsands Petroleum plc (GPX):企業の財務・戦略的SWOT分析
    Summary Gulfsands Petroleum Plc (Gulfsands) is an oil and gas company that offers exploration, development, and production services. The company carries out acquisition, exploration, develops, and produces oil and natural gas. It holds interests in oil exploration and development projects in the Syr …
  • UCO Bank:戦略・SWOT・企業財務分析
    UCO Bank - Strategy, SWOT and Corporate Finance Report Summary UCO Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Schlumberger Ltd (SLB):企業の財務・戦略的SWOT分析
    Schlumberger Ltd (SLB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Seventh Sense Biosystems Inc:医療機器:M&Aディール及び事業提携情報
    Summary Seventh Sense Biosystems Inc (Seventh Sense) is a medical device company that designs, develops and markets blood collection devices for use in research and clinical testing applications. The company’s products include testing devices, TAP devices, sterile and microneedle arrays, among other …
  • Angion Biomedica Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary Angion Biomedica Corp (Angion) is a clinical-stage organ restoration biopharmaceutical company that discovers and develops novel treatments for the treatment of renal and chronic organ injury and disease. The company’s pipeline products include BB3, ANG-3070, ANG-3586, ANG-4201, TBD and ANG- …
  • Shanghai Pudong Development Bank Co., Ltd.:企業の戦略・SWOT・財務情報
    Shanghai Pudong Development Bank Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Shanghai Pudong Development Bank Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • Challenge Group Holdings PTE. LTD.:企業の戦略・SWOT・財務情報
    Challenge Group Holdings PTE. LTD. - Strategy, SWOT and Corporate Finance Report Summary Challenge Group Holdings PTE. LTD. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Splash Corporation:戦略・SWOT・企業財務分析
    Splash Corporation - Strategy, SWOT and Corporate Finance Report Summary Splash Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • SREI Infrastructure Finance Ltd:企業のM&A・事業提携・投資動向
    SREI Infrastructure Finance Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's SREI Infrastructure Finance Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers …
  • First American Financial Corporation:企業のM&A・事業提携・投資動向
    First American Financial Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's First American Financial Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆